- Home
- ELDN vs STIM Comparison
ELDN vs STIM Comparison
Compare ELDN & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- STIM
- Stock Information
- Founded
- ELDN 2004
- STIM 2003
- Country
- ELDN United States
- STIM United States
- Employees
- ELDN N/A
- STIM N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- ELDN Health Care
- STIM Health Care
- Exchange
- ELDN Nasdaq
- STIM Nasdaq
- Market Cap
- ELDN 202.4M
- STIM 224.8M
- IPO Year
- ELDN N/A
- STIM 2018
- Fundamental
- Price
- ELDN $2.73
- STIM $2.90
- Analyst Decision
- ELDN Strong Buy
- STIM Strong Buy
- Analyst Count
- ELDN 2
- STIM 2
- Target Price
- ELDN $12.50
- STIM $7.00
- AVG Volume (30 Days)
- ELDN 998.5K
- STIM 1.2M
- Earning Date
- ELDN 11-11-2025
- STIM 11-11-2025
- Dividend Yield
- ELDN N/A
- STIM N/A
- EPS Growth
- ELDN N/A
- STIM N/A
- EPS
- ELDN 0.21
- STIM N/A
- Revenue
- ELDN N/A
- STIM $111,106,000.00
- Revenue This Year
- ELDN N/A
- STIM $105.70
- Revenue Next Year
- ELDN N/A
- STIM $11.77
- P/E Ratio
- ELDN $12.80
- STIM N/A
- Revenue Growth
- ELDN N/A
- STIM 54.17
- 52 Week Low
- ELDN $2.32
- STIM $0.52
- 52 Week High
- ELDN $5.54
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- ELDN 54.22
- STIM 47.33
- Support Level
- ELDN $2.48
- STIM $2.58
- Resistance Level
- ELDN $2.71
- STIM $3.01
- Average True Range (ATR)
- ELDN 0.17
- STIM 0.18
- MACD
- ELDN 0.04
- STIM 0.04
- Stochastic Oscillator
- ELDN 60.95
- STIM 78.16
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.